Assessing cardiometabolic parameter monitoring in inpatients taking a second-generation antipsychotic: The CAMI-SGA study - a cross-sectional study.

Jennifer FontaineEvelyn ChinJean-François ProvencherAnthony RainoneDana WazzanCarmella RoySoham RejMarie LordkipanidzeVincent Dagenais-Beaulé

Published in: BMJ open (2022)

This study reports suboptimal baseline cardiometabolic monitoring of patients taking an antipsychotic in a Canadian hospital. Optimising collaboration within a multidisciplinary team may increase cardiometabolic monitoring.

Keyphrases

end stage renal disease
healthcare
chronic kidney disease
emergency department
physical activity
palliative care
quality improvement
risk factors
peritoneal dialysis
adverse drug